| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3100355 | Preventive Medicine | 2015 | 7 Pages |
•We examined the studies evaluating contingency management (CM) for substance use disorders in Spain.•The results support the effectiveness of CM with cocaine and tobacco addicts.•Data on the effect of CM on cannabis use disorders (CUD) are still scarce.•CM treatments are not readily adopted into general clinical practice in Spain.
ObjectiveWe provide a narrative review of published studies evaluating voucher-based contingency management (CM) treatment for cocaine, nicotine and cannabis use disorders in Spain and discuss the concerns and future challenges.MethodPublished studies between 2008 and 2015 that evaluated the impact of incentives for SUD in Spain and included an appropriate control or comparison condition were identified and reviewed.ResultsAdding voucher-based CM to standard treatments obtained better treatment retention and cocaine abstinence than standard care alone. CM also improved psychosocial functioning. Economic status or depressive symptoms did not affect the results of CM treatment for cocaine dependence. The addition of a CM protocol to cognitive behavioral treatment (CBT) also improved treatment effectiveness for smoking cessation. Available data on the effect of CM on cannabis use disorders (CUD) with young people did not allow confirmation of its superiority to date.ConclusionThe research conducted to date in Spain confirms and expands the findings of studies conducted in the US supporting the effectiveness of CM in the context of community settings with cocaine- and nicotine-dependents. However, CM has not yet been readily adopted into general clinical practice in Spain or the rest of Europe. The limited effectiveness of CM for CUD is likely due to the scarcity of data and may change with more studies, taking into account recent research on this topic in the US. Continued efforts are warranted to further develop and disseminate incentive-based treatments for SUD across clinical settings and populations in Spain.
